Anika Therapeutics (ANIK) Inventory (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Inventory data on file, last reported at $22.8 million in Q1 2026.

• On a quarterly basis, Inventory rose 7.04% year-over-year to $22.8 million in Q1 2026; TTM through Mar 2026 was $22.8 million, a 7.04% increase from a year earlier, with the FY2025 full-year figure at $18.8 million, down 21.09% from the prior year.
• Inventory for Q1 2026 stood at $22.8 million, up from $18.8 million in the prior quarter.
• Over the last five years, Inventory for ANIK reached as high as $51.5 million in Q2 2024 and fell as low as $16.3 million in Q3 2025.
• Historically, Inventory has averaged $32.9 million across 5 years, with a median of $35.3 million in 2022.
• Across the five-year window, Inventory grew 20.8% in 2024 and slumped 67.12% in 2025, its largest moves.
• Year by year, Inventory stood at $39.8 million in 2022, then slumped by 38.57% to $24.4 million in 2023, then dropped by 2.53% to $23.8 million in 2024, then retreated by 21.09% to $18.8 million in 2025, then climbed by 21.56% to $22.8 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $22.8 million in Q1 2026, $18.8 million in Q4 2025, and $16.3 million in Q3 2025.